Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682367 · ClinicalTrials.gov registry record · Phase 3
Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery
A Phase 3 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 3
- Development phase
- 8
- Enrollment target
NCT03682367: Clinical Trial Phase 3 study, sponsored by University of California, Davis.
NCT03682367 is a Phase 3 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 8 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03682367, a Phase 3 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 8 participants
- Enrollment target
Study Summary
Patients undergoing head and neck cancer surgery often have a lot of pain after surgery, which can lead to a need for a lot of narcotic pain medication. These medications can have many side effects that can make recovery more difficult including nausea, vomiting, dizziness, being overly sleepy, itchiness, inability to urinate, confusion, inability to have a bowel movement, longer time before being able to start walking. These side effects can make the hospital stay longer. The use of gabapentin, which is a non narcotic pain medication that focuses on nerve pain, has been used in smaller head and neck surgeries including removal of tonsils, sinus surgery, thyroid surgery. Studies in patients needing orthopedic or OB/Gyn surgery have shown improved pain control with gabapentin. Potential benefits to future patients include improved pain control, less narcotic associated side effects and faster functional recovery.
Primary Outcome
Determine the difference in average morphine equivalent units between experimental and control group.
Interventions
- DRUG Gabapentin
- DRUG Placebo - Concentrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2020-04-06 |
| Phase | Phase 3 |
Why NCT03682367 stopped before completion
NCT03682367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Gabapentin is the first listed.
NCT03682367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03682367 about?
NCT03682367 is a clinical study titled "Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery". Patients undergoing head and neck cancer surgery often have a lot of pain after surgery, which can lead to a need for a lot of narcotic pain medication. These medications can have many side effects that can make recovery more difficult including nausea, vomiting, dizziness, being overly sleepy, itch...
What is the current status of trial NCT03682367?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 8 participants. The study started on 2018-12-01. Estimated completion is 2020-04-06.
What interventions are being tested in trial NCT03682367?
The interventions under investigation include: Gabapentin (DRUG), Placebo - Concentrate (DRUG).
Who is sponsoring clinical trial NCT03682367?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03682367's enrollment target sits among peer trials
8 1993rd of 2000 higher than 6 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI